ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 8.6d
Immunosuppression Use: Antirejection Treatment from Transplant
to One Year Post Transplant, 1991 to 2000
Recipients with Kidney-Pancreas Transplants

  Year of Transplant
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
Transplants 452 493 661 748 919 860 853 972 938 913
Tx with Antirejection Treatments 327 365 487 493 621 564 311 274 241 198
Antibodies Category Usage 75.5% 75.6% 77.8% 66.1% 47.3% 31.0% 47.3% 43.4% 43.6% 48.0%
ALG 36.1% 31.0% 24.2% 17.4% 8.2% 0.2% 0.0% 0.0% 0.0% 0.0%
ATG 0.3% 0.8% 1.8% 2.0% 6.1% 8.0% 16.4% 8.4% 6.2% 4.0%
NRATG/NRATS 0.0% 0.0% 0.0% 0.0% 0.8% 0.5% 1.6% 1.5% 0.0% 0.0%
OKT3 57.2% 64.4% 66.9% 60.6% 41.2% 24.6% 35.4% 35.0% 25.7% 27.3%
Thymoglobulin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 2.9% 17.0% 17.2%
Zenapax 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 1.1% 1.2% 2.0%
Simulect 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.5%
Corticosteroids Category Usage 82.3% 80.0% 80.7% 76.1% 65.5% 54.1% 68.5% 77.0% 80.1% 79.8%
Prednisone 39.4% 36.7% 30.8% 29.0% 24.2% 12.6% 14.5% 21.2% 31.1% 28.3%
Methylprednisolone 70.3% 70.4% 72.3% 69.4% 57.8% 47.7% 63.3% 69.7% 62.7% 65.2%

Source: OPTN/SRTR Data as of August 1, 2002.
Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.